V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20165859 | 20063529 | 1.9 | null | Palliative (P) | 2016-05-02 | 2016-05-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100805709 |
| 20165866 | 20063530 | 1.86 | 71.8 | Neo-adjuvant (N) | 2017-04-01 | 2017-05-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101211583 |
| 20165867 | 20063531 | 1.82 | 56.9 | Palliative (P) | 2020-01-09 | 2020-02-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101656368 |
| 20165868 | 20063532 | 1.75 | 88.8 | Adjuvant (A) | 2017-05-17 | 2017-05-30 | ECX | 2 | N | ECX | 101425907 |
| 20165873 | 20063533 | 1.7 | 81.15 | Curative (C) | 2016-10-31 | 2016-11-14 | ECX | null | N | CAPECITABINE + GEMCITABINE | 101053669 |
| 20165874 | 20063534 | 1.5 | 69 | Neo-adjuvant (N) | 2018-05-19 | 2018-05-22 | ECX | N | N | ECX | 100047884 |
| 20165879 | 20063535 | 1.56 | 81 | Palliative (P) | null | 2016-02-03 | ECX | null | N | ECX | 100607402 |
| 20165882 | 20063536 | 1.78 | 56.8 | Palliative (P) | 2020-07-16 | 2020-07-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101324193 |
| 20165883 | 20063537 | 1.61 | 47 | Palliative (P) | 2016-11-19 | 2016-12-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101173192 |
| 20165889 | 20063538 | 1.53 | 67.8 | Neo-adjuvant (N) | 2019-11-01 | 2019-11-01 | ECX | N | N | ECX | 100436190 |
| 20165891 | 20063539 | 1.72 | 86 | Neo-adjuvant (N) | 2019-09-05 | 2019-09-18 | ECX | N | N | ECX | 100569282 |
| 20165895 | 20063540 | 1.75 | 81 | Neo-adjuvant (N) | 2016-10-12 | 2016-10-12 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101535247 |
| 20165903 | 20063541 | 1.83 | 73.2 | Adjuvant (A) | 2017-12-08 | 2017-12-23 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101043613 |
| 20165905 | 20063542 | 1.79 | 60.6 | Curative (C) | 2018-12-14 | 2019-01-03 | ECX | N | N | ECX | 101800620 |
| 20165910 | 20063543 | 1.72 | 81.55 | Adjuvant (A) | 2018-09-13 | 2018-09-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100715261 |
| 20165913 | 20063544 | 1.78 | 58.2 | Palliative (P) | 2018-11-18 | 2018-12-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100248651 |
| 20165917 | 20063545 | 1.57 | 80.95 | Adjuvant (A) | 2017-07-22 | 2017-07-24 | ECX | N | null | ECX | 101265998 |
| 20165919 | 20063546 | 1.7 | 68.75 | Curative (C) | 2019-03-09 | 2019-04-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101215391 |
| 20165922 | 20063547 | 1.63 | 77.5 | Palliative (P) | 2017-11-22 | 2018-06-18 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100937808 |
| 20165932 | 20063548 | 1.82 | 87 | Neo-adjuvant (N) | 2016-12-17 | 2016-12-31 | ECX | N | N | ECX | 101038476 |
| 20165933 | 20063549 | 1.7 | 70 | Neo-adjuvant (N) | 2016-10-27 | 2016-10-27 | ECX | 02 | N | ECX | 100480714 |
| 20165938 | 20063550 | 1.55 | 61 | null | 2017-12-12 | 2018-01-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100946138 |
| 20165957 | 20063551 | 1.69 | 100.6 | Neo-adjuvant (N) | 2019-09-01 | 2019-09-08 | ECX | 02 | N | ECX | 100180077 |
| 20165961 | 20063552 | 1.72 | 76 | Palliative (P) | 2019-07-15 | 2019-07-28 | ECX | N | Y | ECX | 101278421 |
| 20165969 | 20063553 | null | null | Palliative (P) | 2018-02-23 | 2018-03-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100723256 |
| 20165970 | 20063554 | 1.57 | 74.8 | Adjuvant (A) | 2019-12-20 | 2019-12-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100565971 |
| 20165973 | 20063555 | 1.47 | 68.4 | Neo-adjuvant (N) | 2016-08-22 | 2016-08-29 | ECX | N | N | ECX | 100716094 |
| 20165979 | 20063556 | 1.59 | 67.9 | Neo-adjuvant (N) | 2020-01-02 | 2020-01-14 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101402286 |
| 20165980 | 20063557 | 1.53 | 98.2 | Palliative (P) | 2019-08-03 | 2019-08-11 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100318395 |
| 20165981 | 20063558 | 1.78 | 106.8 | Palliative (P) | 2017-03-12 | 2017-03-19 | ECX | 02 | N | ECX | 100934763 |
| 20165986 | 20063559 | 1.53 | 74.6 | null | 2017-07-18 | 2017-07-18 | ECX | 02 | N | ECX | 100808975 |
| 20165987 | 20063560 | 1.62 | 69.4 | Neo-adjuvant (N) | 2017-06-04 | 2017-06-12 | ECX | N | N | ECX | 100373176 |
| 20165991 | 20063561 | 1.82 | 70 | Palliative (P) | 2019-07-18 | 2019-07-25 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100703052 |
| 20165999 | 20063562 | 1.73 | 72.2 | Neo-adjuvant (N) | 2017-10-31 | 2017-11-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100513350 |
| 20166001 | 20063563 | 1.72 | 74.1 | Palliative (P) | 2019-07-22 | 2019-07-30 | ECX | N | N | ECX | 100513042 |
| 20166007 | 20063564 | 1.72 | 57 | Neo-adjuvant (N) | 2017-07-23 | 2017-07-23 | ECX | 2 | N | ECX | 100679097 |
| 20166030 | 20063565 | 1.51 | 59.2 | Curative (C) | 2017-01-23 | 2017-02-04 | ECX | 02 | N | ECX | 100434792 |
| 20166032 | 20063566 | 1.61 | 64.7 | Neo-adjuvant (N) | 2019-01-01 | 2019-01-02 | ECX | N | N | ECX | 100241403 |
| 20166045 | 20063567 | 1.75 | 90.4 | Palliative (P) | 2016-12-08 | 2016-12-09 | ECX | 02 | N | ECX | 100200881 |
| 20166050 | 20063568 | null | null | Neo-adjuvant (N) | null | 2018-09-11 | ECX | N | N | ECX | 101118578 |
| 20166057 | 20063569 | 1.79 | 99.5 | Palliative (P) | 2017-02-08 | 2017-02-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100154462 |
| 20166058 | 20063570 | 1.67 | 66 | Palliative (P) | 2018-05-23 | 2018-06-05 | ECX | N | N | ECX | 101448646 |
| 20166069 | 20063571 | 1.78 | 110 | null | 2016-12-19 | 2017-01-07 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100106535 |
| 20166070 | 20063572 | 1.69 | 104 | Adjuvant (A) | 2018-03-09 | 2018-03-09 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101042808 |
| 20166073 | 20063573 | 1.52 | 74.9 | Adjuvant (A) | 2017-04-22 | 2017-04-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100525996 |
| 20166075 | 20063574 | 1.58 | 62.75 | Disease modification (D) | 2017-06-08 | 2017-06-08 | ECX | null | N | ECX | 101035293 |
| 20166080 | 20063575 | 1.51 | 78 | Palliative (P) | 2019-05-19 | 2019-06-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100319585 |
| 20166081 | 20063576 | 1.78 | 106 | Palliative (P) | 2017-11-02 | 2017-11-22 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100577078 |
| 20166090 | 20063577 | 1.69 | 75 | null | null | 2019-10-20 | ECX | null | N | CAPECITABINE + GEMCITABINE | 101384247 |
| 20166091 | 20063578 | 1.75 | 73.4 | null | 2019-12-15 | 2020-01-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100613816 |